Systems and methods for binary tissue classification
US-2021150707-A1 · May 20, 2021 · US
US2025067638A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2025067638-A1 |
| Application number | US-202418943398-A |
| Country | US |
| Kind code | A1 |
| Filing date | Nov 11, 2024 |
| Priority date | Oct 25, 2021 |
| Publication date | Feb 27, 2025 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Disclosed herein, inter alia, are devices and methods for transfer and analysis of tissue sections using carrier substrates.
Opening claim text (preview).
What is claimed is: 1 . A device comprising: a solid support comprising a plurality of discrete tissue samples attached to the solid support, wherein each discrete tissue sample comprises: a tissue section comprising a width of about 4 mm to about 10 mm and a thickness of about 5 μm to about 12 μm; and a hydrogel substrate attached to the tissue section. 2 . The device of claim 1 , wherein each tissue section is a formalin-fixed and paraffin embedded (FFPE) tissue section. 3 . The device of claim 1 , wherein each tissue section is a frozen tissue section. 4 . The device of claim 1 , wherein a length, width, and/or diameter of each tissue section is about 4 mm to about 10 mm. 5 . The device of claim 1 , wherein a thickness of each tissue section is about 1 μm to about 20 μm. 6 . The device of claim 1 , wherein a thickness of each tissue section is less than 6 μm, 7 μm, 8 μm, 9 μm or 10 μm. 7 . The device of claim 1 , wherein each tissue section comprises breast tissue, lung tissue, colon tissue, lymph tissue, kidney tissue, bone tissue, tonsil tissue, or brain tissue. 8 . The device of claim 1 , wherein each tissue section bonds to the hydrogel substrate via a first bond having a first adhesion strength, and wherein the tissue section bonds to the solid support via a second bond having a second adhesion strength, wherein the second adhesion strength is greater than the first adhesion strength. 9 . The device of claim 1 , wherein the hydrogel substrate comprises agarose, amylose, or amylopectin. 10 . The device of claim 1 , wherein the hydrogel substrate comprises 2% to 5% agarose. 11 . The device of claim 1 wherein the hydrogel substrate comprises 3% to 20% acrylamide. 12 . The device of claim 1 , wherein the solid support is glass. 13 . A method of detecting nucleic acids in a tissue section, comprising: contacting the device of claim 1 with a plurality of circularizable probes, wherein a circularizable probe binds to a nucleic acid molecule in the tissue section; forming a circular oligonucleotide in the tissue section, and amplifying the circular oligonucleotide to form amplification products; and detecting the amplification products by binding a fluorescently labeled probe to the amplification product and detecting the fluorescent label. 14 . The method of claim 13 , wherein prior to contacting the device with a plurality of circularizable probes, the hydrogel substrate is removed. 15 . The method of claim 13 , wherein the nucleic acid molecule is attached to a specific binding agent. 16 . The method of claim 13 , wherein the nucleic acid molecule is an RNA molecule. 17 . The method of claim 13 , wherein the nucleic acid molecule is a cDNA molecule. 18 . The method of claim 13 , where the tissue section comprises is liver tissue, kidney tissue, lung tissue, thymus tissue, adrenal tissue, skin tissue, bladder tissue, colon tissue, spleen tissue, or brain tissue. 19 . The method of claim 13 , wherein the fluorescently labeled probe is a fluorescently labeled nucleotide. 20 . The method of claim 13 , wherein the fluorescently labeled probe is a fluorescently labeled oligonucleotide.
Reducing the nucleic acid content · CPC title
with fluorescent label · CPC title
Nucleic acid amplification reactions · CPC title
Enzymatic or biochemical coupling of nucleic acids to a solid phase · CPC title
Nucleic acid detection involving sensors · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.